Wang J - Search Results

1

Global, regional, and national burden of chronic kidney disease attributable to high sodium intake from 1990 to 2019.

Liu W, Zhou L, Yin W, Wang J, Zuo X. Liu W, et al. Among authors: wang j. Front Nutr. 2023 Mar 2;10:1078371. doi: 10.3389/fnut.2023.1078371. eCollection 2023. Front Nutr. 2023. PMID: 36937353 Free PMC article.

2

Effect of CYP3A5*3 polymorphism on pharmacokinetic drug interaction between tacrolimus and amlodipine.

Zuo XC, Zhou YN, Zhang BK, Yang GP, Cheng ZN, Yuan H, Ouyang DS, Liu SK, Barrett JS, Li PJ, Liu Z, Tan HY, Guo R, Zhou LY, Xie YL, Li ZJ, Li J, Wang CJ, Wang JL. Zuo XC, et al. Among authors: wang jl, wang cj. Drug Metab Pharmacokinet. 2013;28(5):398-405. doi: 10.2133/dmpk.dmpk-12-rg-148. Epub 2013 Feb 26. Drug Metab Pharmacokinet. 2013. PMID: 23438946 Free article. Clinical Trial.

3

ABCB1 polymorphism and gender affect the pharmacokinetics of amlodipine in Chinese patients with essential hypertension: a population analysis.

Zuo XC, Zhang WL, Yuan H, Barrett JS, Hua Y, Huang ZJ, Zhou HH, Pei Q, Guo CX, Wang JL, Yang GP. Zuo XC, et al. Drug Metab Pharmacokinet. 2014;29(4):305-11. doi: 10.2133/dmpk.dmpk-13-rg-127. Epub 2014 Feb 11. Drug Metab Pharmacokinet. 2014. PMID: 24522199 Free article. Clinical Trial.

4

Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients.

Wang J, Guo R, Liu S, Chen Q, Zuo S, Yang M, Zuo X. Wang J, et al. Chin Med J (Engl). 2014;127(20):3645-50. Chin Med J (Engl). 2014. PMID: 25316243 Review.

5

Tacrolimus decreases insulin sensitivity without reducing fasting insulin concentration: a 2-year follow-up study in kidney transplant recipients.

Chen QJ, Li J, Zuo SR, Zhang YP, Jia SJ, Yuan H, Liu SK, Cheng K, Ming YZ, Zuo XC, Luo AJ, Xie WZ, Cai JJ, Yang M, Wang JL. Chen QJ, et al. Among authors: wang jl. Ren Fail. 2015 May;37(4):601-6. doi: 10.3109/0886022X.2015.1007833. Epub 2015 Feb 3. Ren Fail. 2015. PMID: 25644968

6

The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases.

Chen Q, Guan X, Zuo X, Wang J, Yin W. Chen Q, et al. Among authors: wang j. Acta Pharm Sin B. 2016 May;6(3):183-8. doi: 10.1016/j.apsb.2016.02.004. Epub 2016 Mar 7. Acta Pharm Sin B. 2016. PMID: 27175328 Free PMC article. Review.

7

Contrast Media-Induced Renal Inflammation Is Mediated Through HMGB1 and Its Receptors in Human Tubular Cells.

Guan XF, Chen QJ, Zuo XC, Guo R, Peng XD, Wang JL, Yin WJ, Li DY. Guan XF, et al. DNA Cell Biol. 2017 Jan;36(1):67-76. doi: 10.1089/dna.2016.3463. Epub 2016 Nov 9. DNA Cell Biol. 2017. PMID: 27828735

8

Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients.

Yin WJ, Yi YH, Guan XF, Zhou LY, Wang JL, Li DY, Zuo XC. Yin WJ, et al. J Am Heart Assoc. 2017 Feb 3;6(2):e004498. doi: 10.1161/JAHA.116.004498. J Am Heart Assoc. 2017. PMID: 28159819 Free PMC article. Clinical Trial.

9

Dlitiazem inhibits the oxidative stress induced by angiotensin II through growth hormone secretagogue receptor type 1a in human umbilicus vein endothelial cells.

Zhou L, Yang M, Zuo S, Guan X, Wang J, Chen Q, Zuo X, Jia S, Guo R. Zhou L, et al. Among authors: wang j. Biomed Pharmacother. 2017 May;89:76-82. doi: 10.1016/j.biopha.2017.02.022. Epub 2017 Feb 17. Biomed Pharmacother. 2017. PMID: 28214691

10

Population Pharmacokinetic Modeling of Diltiazem in Chinese Renal Transplant Recipients.

Guan XF, Li DY, Yin WJ, Ding JJ, Zhou LY, Wang JL, Ma RR, Zuo XC. Guan XF, et al. Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):55-62. doi: 10.1007/s13318-017-0425-y. Eur J Drug Metab Pharmacokinet. 2018. PMID: 28646274 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203,652 results

Search Page